Sutro Biopharma(DE:S090)
€11.500.00 (0.00%)
DE:S090
Sutro Biopharma financials statements
€11.50
At close:0.00 (0.00%)
Sutro Biopharma (S090) Income Statement
1 Followers
Sutro Biopharma Income Statement
Last quarter (Q3 2026), Sutro Biopharma's total revenue was $9.10M, a decrease of 6.14% from the same quarter last year. In Q3, Sutro Biopharma's net income was $-31.49M. See Sutro Biopharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 102.48M | $ 62.04M | $ 153.73M | $ 67.77M | $ 61.88M | |
| $ 95.16M | $ 54.83M | $ 146.91M | $ 59.48M | $ 52.11M | |
| $ 200.11M | $ 293.28M | $ 236.19M | $ 188.43M | $ 150.63M | |
| Depreciation and Amortization | $ 7.32M | $ 7.22M | $ 6.82M | $ 5.69M | $ 4.84M |
| $ -145.65M | $ -180.45M | $ -67.92M | $ -107.67M | $ -97.56M | |
| $ -104.95M | $ -238.45M | $ -89.28M | $ -128.94M | $ -98.52M | |
| $ -86.23M | $ 13.36M | $ 677.00K | $ 12.24M | $ -7.01M | |
| $ -191.18M | $ -225.10M | $ -88.60M | $ -116.70M | $ -105.54M | |
| $ -191.09M | $ -227.46M | $ -106.79M | $ -119.20M | $ -105.54M | |
| Per Share Metrics | |||||
| Basic EPS | $ -22.49 | $ -29.60 | $ -17.80 | $ -23.50 | $ -22.90 |
| Diluted EPS | $ -22.49 | $ -29.60 | $ -17.80 | $ -23.50 | $ -22.90 |
| Weighted Average Shares Outstanding | 8.50M | 7.68M | 6.02M | 5.07M | 4.61M |
| Weighted Average Shares Outstanding (Diluted) | 8.50M | 7.68M | 6.02M | 5.07M | 4.61M |
Currency in USD

